Search Filters

Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)

Status: Published on

The aim of this rapid Health Technology Assessment was to inform a decision on expanding the influenza vaccination programme in Ireland to include reimbursement of standard quadrivalent influenza vaccines (QIVs) for those aged 50 to 64 years old in the general population (that is, those not at increased risk of severe disease from influenza).   

HTA Flu Vaccine Extension

Supporting Documents

  • Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)

    Download

  • Extension of the influenza vaccination programme to include those aged 50 to 64 years (general population) Protocol for a Rapid Health Technology Assessment

    Download